Music |
Video |
Movies |
Chart |
Show |
Lenvatinib Plus Pembrolizumab After Progression on Immune Checkpoint Inhibitors for Metastatic RCC (PracticeUpdate) View |
VEGFR inhibitors with immune checkpoint inhibitors for advanced renal cancer (VJOncology) View |
Researcher comment: The KEYNOTE-146/Study 111 trial | Chung-Han Lee (Medicine Matters oncology) View |
Lenvatinib and Pembrolizumab Compared to Sunitinib for Advanced Renal Cell Carcinoma (PracticeUpdate) View |
Health-Related Quality of Life With Lenvatinib Plus Pembrolizumab for Patients With Advanced RCC (PracticeUpdate) View |
Second-Line Therapy After I/O in mRCC (OncLive) View |
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progressi... (ecancer) View |
Lenvatinib and Everolimus for Advanced RCC (Targeted Oncology) View |
Lenvatinib: New Kid on the Block (OncLive) View |
KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with... (ecancer) View |